AAAAAA

   
Results: 1-18 |
Results: 18
Low adjusted-dose acenocoumarol therapy in sickle cell disease: A pilot study
Authors: Schnog, JB Kater, AP Mac Gillavry, MR Duits, AJ Lard, LR van der Dijs, FPL Brandjes, DPM ten Cate, H van Eps, LWS Rojer, RA
Citation: Jb. Schnog et al., Low adjusted-dose acenocoumarol therapy in sickle cell disease: A pilot study, AM J HEMAT, 68(3), 2001, pp. 179-183
Question and answer session after scientific review
Authors: ten Cate, H Esmon, C van Deventer, S
Citation: H. Ten Cate et al., Question and answer session after scientific review, CRIT CARE M, 29(7), 2001, pp. S51-S52
Microvascular coagulopathy and disseminated intravascular coagulation
Authors: ten Cate, H Schoenmakers, SHHF Franco, R Timmerman, JJ Groot, AP Spek, A Reitsma, PH
Citation: H. Ten Cate et al., Microvascular coagulopathy and disseminated intravascular coagulation, CRIT CARE M, 29(7), 2001, pp. S95-S97
Microvascular coagulopathy and disseminated intravascular coagulation - Question and answer session after scientific review
Authors: Esmon, C ten Cate, H Hack, CE Sprung, C
Citation: C. Esmon et al., Microvascular coagulopathy and disseminated intravascular coagulation - Question and answer session after scientific review, CRIT CARE M, 29(7), 2001, pp. S97-S98
Clinical expert round table discussion (session 4) at the Margaux Conference on Critical Illness: Sepsis: Inflammation disorder, coagulation disorder, or both? A challenge for clinicians
Authors: Carlet, J Taylor, F Levi, M Artigas, A ten Cate, H Marshall, J
Citation: J. Carlet et al., Clinical expert round table discussion (session 4) at the Margaux Conference on Critical Illness: Sepsis: Inflammation disorder, coagulation disorder, or both? A challenge for clinicians, CRIT CARE M, 29(7), 2001, pp. S107-S108
Activation of coagulation factor XI, without detectable contact activationin dengue haemorrhagic fever
Authors: van Gorp, ECM Minnema, MC Suharti, C Mairuhu, ATA Brandjes, DPM ten Cate, H Hack, CE Meijers, JCM
Citation: Ecm. Van Gorp et al., Activation of coagulation factor XI, without detectable contact activationin dengue haemorrhagic fever, BR J HAEM, 113(1), 2001, pp. 94-99
Activation of clotting factors XI and IX in patients with acute myocardialinfarction
Authors: Minnema, MC Peters, RJG de Winter, R Lubbers, YPT Barzegar, S Bauer, KA Rosenberg, RD Hack, CE ten Cate, H
Citation: Mc. Minnema et al., Activation of clotting factors XI and IX in patients with acute myocardialinfarction, ART THROM V, 20(11), 2000, pp. 2489-2493
Pathophysiology of disseminated intravascular coagulation in sepsis
Authors: ten Cate, H
Citation: H. Ten Cate, Pathophysiology of disseminated intravascular coagulation in sepsis, CRIT CARE M, 28(9), 2000, pp. S9-S11
Novel approaches to the management of disseminated intravascular coagulation
Authors: Levi, M de Jonge, E van der Poll, T ten Cate, H
Citation: M. Levi et al., Novel approaches to the management of disseminated intravascular coagulation, CRIT CARE M, 28(9), 2000, pp. S20-S24
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Authors: Franco, RF de Jonge, E Dekkers, PEP Timmerman, JJ Spek, CA van Deventer, SJH van Deursen, P van Kerkhoff, L van Gemen, B ten Cate, H van der Poll, T Reitsma, PH
Citation: Rf. Franco et al., The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation, BLOOD, 96(2), 2000, pp. 554-559
Activation of the contact system of coagulation does not contribute to thehemostatic imbalance in hypertriglyceridemia
Authors: Minnema, MC Wittekoek, ME Schoonenboom, N Kastelein, JJP Hack, CE ten Cate, H
Citation: Mc. Minnema et al., Activation of the contact system of coagulation does not contribute to thehemostatic imbalance in hypertriglyceridemia, ART THROM V, 19(10), 1999, pp. 2548-2553
Disseminated intravascular coagulation
Authors: Levi, M de Jonge, E van der Poll, T ten Cate, H
Citation: M. Levi et al., Disseminated intravascular coagulation, THROMB HAEM, 82(2), 1999, pp. 695-705
Disseminated intravascular coagulation: Clinical spectrum and established as well as new diagnostic approaches
Authors: Muller-Berghaus, G ten Cate, H Levi, M
Citation: G. Muller-berghaus et al., Disseminated intravascular coagulation: Clinical spectrum and established as well as new diagnostic approaches, THROMB HAEM, 82(2), 1999, pp. 706-712
The pathophysiology of disseminated intravascular coagulation
Authors: ten Cate, H Timmerman, JJ Levi, M
Citation: H. Ten Cate et al., The pathophysiology of disseminated intravascular coagulation, THROMB HAEM, 82(2), 1999, pp. 713-717
Current concepts - Disseminated intravascular coagulation
Authors: Levi, M ten Cate, H
Citation: M. Levi et H. Ten Cate, Current concepts - Disseminated intravascular coagulation, N ENG J MED, 341(8), 1999, pp. 586-592
Disseminated intravascular coagulation - Reply
Authors: Levi, M ten Cate, H
Citation: M. Levi et H. Ten Cate, Disseminated intravascular coagulation - Reply, N ENG J MED, 341(25), 1999, pp. 1938-1938
Review: Infections diseases and coagulation disorders
Authors: van Gorp, ECM Suharti, C ten Cate, H Dolmans, WMV van der Meer, JWM ten Cate, JW Brandjes, DPM
Citation: Ecm. Van Gorp et al., Review: Infections diseases and coagulation disorders, J INFEC DIS, 180(1), 1999, pp. 176-186
The 20210 G -> A mutation in the 3 '-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease
Authors: Franco, RF Trip, MD ten Cate, H van den Ende, A Prins, MH Kastelein, JJP Reitsma, PH
Citation: Rf. Franco et al., The 20210 G -> A mutation in the 3 '-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease, BR J HAEM, 104(1), 1999, pp. 50-54
Risultati: 1-18 |